Pendinghealth
New CRISPR variant edits mitochondrial DNA in vivo
Summary
Researchers at the Broad Institute demonstrated a modified CRISPR-Cas13 system capable of editing mitochondrial DNA in living mice, opening treatment pathways for mitochondrial diseases.
Details
Submitter0xf2a3...b4c5
Reputation93
Bond550 PLOT
SubmittedMon, 21 Apr 2025 09:00:00 GMT (12mo ago)
ArweaveNot archived
Sources (1)
https://broadinstitute.org/mito-crispr-2025
Verification Timeline
12mo agoClaim submitted0xf2a3...b4c5
12mo ago550 PLOT bonded0xf2a3...b4c5
12mo ago1 source(s) attached0xf2a3...b4c5